1. p53
    Aundrietta D. Duncan et al, 2015, Signaling Pathways in Liver Diseases CrossRef
  2. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
    Wei Dai et al, 2016, Molecular Medicine Reports CrossRef
  3. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency
    Kan Toriguchi et al, 2014, Journal of Gastroenterology and Hepatology CrossRef
  4. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
    Wan-Jiang Xue et al, 2016, Scientific Reports CrossRef
  5. Tissue Microarray Immunohistochemical Profiles of p53 and pRB in Hepatocellular Carcinoma and Hepatoblastoma
    Abdul Hadi Azlin et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  6. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma
    Eric Waidely et al, 2017, Analytical Chemistry CrossRef
  7. 6‐Methoxyethylamino‐numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib
    Yanning Liu et al, 2017, The FASEB Journal CrossRef
  8. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
    Yanling Liu et al, 2020, Nanoscale Research Letters CrossRef
  9. B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma
    MITSURO KANDA et al, 2015, International Journal of Oncology CrossRef
  10. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma
    Vanderlei Segatelli et al, 2014, Hepatology International CrossRef
  11. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)
    KATSUNORI YOSHIDA et al, 2014, International Journal of Oncology CrossRef
  12. Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy
    RYOJI HASHIMOTO et al, 2015, Oncology Letters CrossRef
  13. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
    Qiong Wu et al, 2018, Cell Death & Disease CrossRef
  14. Expanding knowledge on Russula alatoreticula, a novel mushroom from tribal cuisine, with chemical and pharmaceutical relevance
    Somanjana Khatua et al, 2019, Cytotechnology CrossRef
  15. BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC6 with p53 facilitating p53 degradation
    Wenqing Tang et al, 2015, International Journal of Cancer CrossRef
  16. Dynamin 3 suppresses growth and induces apoptosis of hepatocellular carcinoma cells by activating inducible nitric oxide synthase production
    Chao Gu et al, 2017, Oncology Letters CrossRef
  17. Exome Sequencing of Fresh-frozen or Formalin-fixed Paraffin-embedded B6C3F1/N Mouse Hepatocellular Carcinomas Arising Either Spontaneously or due to Chronic Chemical Exposure
    Scott S. Auerbach et al, 2018, Toxicologic Pathology CrossRef
  18. The role of DNA damage and repair in liver cancer
    Rhys Gillman et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  19. Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research
    Jerry D. Monroe et al, 2021, Cells CrossRef
  20. Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis
    Zhiqiang Qin et al, 2018, World Journal of Surgical Oncology CrossRef
  21. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma
    Li Wang et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
  22. Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructure
    Mohammad Heiat et al, 2019, Microchemical Journal CrossRef
  23. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
    Eric Waidely et al, 2016, The Analyst CrossRef
  24. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells
    Irma Magaly Rivas Serna et al, 2020, International Journal of Molecular Sciences CrossRef
  25. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
    Maria Cristina Bonferoni et al, 2020, Nanomaterials CrossRef
  26. Mechanism studies on anti-HepG2 cell proliferation of phenanthroline derivatives as G-quadruplex DNA stabilizers
    Huiqing Li et al, 2015, Bioorganic & Medicinal Chemistry Letters CrossRef
  27. Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma
    DENG-QING LI et al, 2016, Oncology Letters CrossRef
  28. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo
    Fangyi Li et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  29. The Suppressive Role of SOX7 in Hepatocarcinogenesis
    Chong Wang et al, 2014, PLoS ONE CrossRef
  30. The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets
    Jianzhou Cui et al, 2020, Pharmaceuticals CrossRef
  31. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo
    Min Yao et al, 2016, Tumor Biology CrossRef
  32. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI
    Kazuki Takeishi et al, 2020, Annals of Surgical Oncology CrossRef
  33. DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss
    Chieh-Hsiang Chan et al, 2019, Molecular Cancer Research CrossRef
  34. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma
    Tomoyuki Honda et al, 2019, International Journal of Molecular Sciences CrossRef
  35. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues
    Anchalee Tantiwetrueangdet et al, 2021, BMC Cancer CrossRef
  36. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma
    MITSURO KANDA et al, 2014, International Journal of Oncology CrossRef
  37. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling
    DONG WANG et al, 2014, International Journal of Oncology CrossRef
  38. Increased ARPP-19 Expression Is Associated with Hepatocellular Carcinoma
    Haiyan Song et al, 2014, International Journal of Molecular Sciences CrossRef
  39. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
    Fei Ji et al, 2018, BMC Cancer CrossRef
  40. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)
    Yue Jia et al, 2019, Experimental and Molecular Pathology CrossRef
  41. p53 in liver pathologies—taking the good with the bad
    Meital Charni et al, 2014, Journal of Molecular Medicine CrossRef
  42. Heat Shock Protein 90α–Dependent B‐Cell‐2–Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto‐Oncogene c‐MYC mRNA Stability
    Xueqiong Zhou et al, 2019, Hepatology CrossRef
  43. Interaction of Mitochondrial and Epigenetic Regulation in Hepatocellular Carcinoma
    Victoria Chagoya de Sánchez et al, 2018, Liver Cancer CrossRef
  44. The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development
    Gaetano Romano, 2013, Scientifica CrossRef
  45. Animal models as a tool in hepatocellular carcinoma research: A Review
    Nuno Paula Santos et al, 2017, Tumor Biology CrossRef
  46. Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression
    Xiao-Ke Cheng et al, 2017, Oncotarget CrossRef
  47. Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer
    Myong Cheol Lim et al, 2016, Cancer Research and Treatment CrossRef
  48. miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma
    JIYE FENG et al, 2015, Oncology Reports CrossRef
  49. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes
    Ai-Guo Wang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  50. NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
    Wenshuang Zou et al, 2018, Medicine CrossRef
  51. Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer
    Lei Qu et al, 2014, Cancer Cell International CrossRef
  52. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy
    Hye-Lim Ju et al, 2016, International Journal of Cancer CrossRef
  53. The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population
    John Carson Allen et al, 2016, Medicine CrossRef
  54. The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells
    Caixia Zhang et al, 2013, Biochemical and Biophysical Research Communications CrossRef
  55. Inhibition of Hedgehog signaling in the gastrointestinal tract: Targeting the cancer microenvironment
    Juanita L. Merchant et al, 2014, Cancer Treatment Reviews CrossRef
  56. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells
    Bo Peng et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
  57. Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells
    Shuang Chen et al, 2018, Anti-Cancer Drugs CrossRef
  58. TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells
    Z Zhang et al, 2015, Oncogene CrossRef
  59. Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma
    MING QI et al, 2015, Molecular Medicine Reports CrossRef
  60. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein–Dependent Apoptotic Pathway
    Long-Kuan Ran et al, 2016, Clinical Cancer Research CrossRef
  61. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma
    Jen-Eing Jeng et al, 2014, Tumor Biology CrossRef
  62. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4
    Junhu Wan et al, 2019, International Journal of Cancer CrossRef
  63. Anaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinoma
    JIANHUA LIU et al, 2016, Oncology Letters CrossRef
  64. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma
    Jing Kong et al, 2015, Human Gene Therapy Methods CrossRef
  65. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle
    YUAN TIAN et al, 2013, International Journal of Oncology CrossRef
  66. Hepatitis B virus inhibits the expression of CD82 through hypermethylation of its promoter in hepatoma cells
    GUOZHENG YU et al, 2014, Molecular Medicine Reports CrossRef
  67. Ras-induced Epigenetic Inactivation of the RRAD (Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model
    Yan Wang et al, 2014, Journal of Biological Chemistry CrossRef
  68. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma
    Tiffany Hennedige, 2016, World Journal of Gastroenterology CrossRef
  69. NRAGE promotes the malignant phenotype of hepatocellular carcinoma
    DAI SHIMIZU et al, 2016, Oncology Letters CrossRef
  70. Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis
    Yehong Liu et al, 2016, International Journal of Molecular Medicine CrossRef
  71. Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma
    Nada H Eisa et al, 2015, Journal of Oncology Pharmacy Practice CrossRef
  72. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
    Tony Gutschner et al, 2014, Hepatology CrossRef
  73. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
    Fei Wang et al, 2016, Oncotarget CrossRef
  74. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance
    Byung Ihn Choi et al, 2015, American Journal of Roentgenology CrossRef
  75. Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study
    Dina M. Rasheed Bahgat et al, 2016, Journal of Clinical Laboratory Analysis CrossRef
  76. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
    Ayesha Khalid et al, 2017, Tumor Biology CrossRef